Hira A Awan,Muhammad F A Chaudhary,Anthony D El-Sokkary,Eric A Hoffman,Alejandro P Comellas,Junfeng Guo,Igor Z Barjaktarevic,R Graham Barr,Surya P Bhatt,Sandeep Bodduluri,Russell P Bowler,Luis G Vargas Buonfiglio,Christopher B Cooper,Ashraf Fawzy,Annette T Hastie,Wassim W Labaki,Fernando J Martinez,Martha G Menchaca,Wanda O'Neal,Robert Paine,Joyce D Schroeder,Prescott G Woodruff,Jeffrey L Curtis,Joseph M Reinhardt
{"title":"Lung Quantitative Computed Tomography Textures are Associated with Systemic Inflammation and Mortality in COPD.","authors":"Hira A Awan,Muhammad F A Chaudhary,Anthony D El-Sokkary,Eric A Hoffman,Alejandro P Comellas,Junfeng Guo,Igor Z Barjaktarevic,R Graham Barr,Surya P Bhatt,Sandeep Bodduluri,Russell P Bowler,Luis G Vargas Buonfiglio,Christopher B Cooper,Ashraf Fawzy,Annette T Hastie,Wassim W Labaki,Fernando J Martinez,Martha G Menchaca,Wanda O'Neal,Robert Paine,Joyce D Schroeder,Prescott G Woodruff,Jeffrey L Curtis,Joseph M Reinhardt","doi":"10.1016/j.chest.2025.04.017","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nChronic obstructive pulmonary disease (COPD) is characterized by persistent inflammation that is responsible for remodeling the bronchovascular bundles, which may lead to poor quality of life. Quantitative computed tomography (QCT) textures of the lung can capture local disease patterns of inflammation and related respiratory morbidity.\r\n\r\nRESEARCH QUESTION\r\nAre bronchovascular bundle textures, obtained from the adaptive multiple feature method (AMFM), associated with systemic inflammation, morbidity, and mortality in COPD?\r\n\r\nSTUDY DESIGN AND METHODS\r\nWe analyzed data from the SPIROMICS (n = 2,981) and COPDGene (n = 10,305) studies. The predictors included two QCT biomarkers, the bronchovascular bundles (BVB) and CT density gradient (CTDG) textures, age, sex, BMI, race, smoking status, smoking pack-years, CT emphysema, and Pi10 (airway wall thickness). Outcomes included plasma biomarker concentrations from Meso Scale Discovery proteomics assays and complete blood counts, both as markers of inflammation, along with FEV1, FEV1/FVC ratio, SGRQ, 6MWD, and mMRC dyspnea scale. Associations of these QCT textures with FEV1 decline and all-cause mortality were also investigated.\r\n\r\nRESULTS\r\nIncreased BVB texture was significantly associated with elevated neutrophil and monocyte counts, and the neutrophil-to-lymphocyte ratio (NLR), independent of clinical covariates, CT emphysema, and Pi10. Elevated CTDG was associated with increased neutrophil count, NLR, and tumor necrosis factor (TNF)-α. Increased CTDG and BVB textures were also associated with a lower FEV1 and six-minute walk distance. CTDG at baseline was also associated with decline in FEV1 at five-year follow-up in COPDGene. We observed a significant association of both BVB (HRSPIROMICS=1.084, 95% CI: 1.035, 1.135, P<0.001; HRCOPDGene=1.106, 95% CI: 1.080, 1.131, P<0.001) and CTDG (HRSPIROMICS=1.033, 95% CI: 1.003, 1.064, P=0.03; HRCOPDGene=1.079, 95% CI: 1.061, 1.096, P<0.001) textures with all-cause mortality independent of CT emphysema and Pi10.\r\n\r\nINTERPRETATION\r\nQCT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and overall disease burden in COPD.","PeriodicalId":9782,"journal":{"name":"Chest","volume":"53 1","pages":""},"PeriodicalIF":9.5000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2025.04.017","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Chronic obstructive pulmonary disease (COPD) is characterized by persistent inflammation that is responsible for remodeling the bronchovascular bundles, which may lead to poor quality of life. Quantitative computed tomography (QCT) textures of the lung can capture local disease patterns of inflammation and related respiratory morbidity.
RESEARCH QUESTION
Are bronchovascular bundle textures, obtained from the adaptive multiple feature method (AMFM), associated with systemic inflammation, morbidity, and mortality in COPD?
STUDY DESIGN AND METHODS
We analyzed data from the SPIROMICS (n = 2,981) and COPDGene (n = 10,305) studies. The predictors included two QCT biomarkers, the bronchovascular bundles (BVB) and CT density gradient (CTDG) textures, age, sex, BMI, race, smoking status, smoking pack-years, CT emphysema, and Pi10 (airway wall thickness). Outcomes included plasma biomarker concentrations from Meso Scale Discovery proteomics assays and complete blood counts, both as markers of inflammation, along with FEV1, FEV1/FVC ratio, SGRQ, 6MWD, and mMRC dyspnea scale. Associations of these QCT textures with FEV1 decline and all-cause mortality were also investigated.
RESULTS
Increased BVB texture was significantly associated with elevated neutrophil and monocyte counts, and the neutrophil-to-lymphocyte ratio (NLR), independent of clinical covariates, CT emphysema, and Pi10. Elevated CTDG was associated with increased neutrophil count, NLR, and tumor necrosis factor (TNF)-α. Increased CTDG and BVB textures were also associated with a lower FEV1 and six-minute walk distance. CTDG at baseline was also associated with decline in FEV1 at five-year follow-up in COPDGene. We observed a significant association of both BVB (HRSPIROMICS=1.084, 95% CI: 1.035, 1.135, P<0.001; HRCOPDGene=1.106, 95% CI: 1.080, 1.131, P<0.001) and CTDG (HRSPIROMICS=1.033, 95% CI: 1.003, 1.064, P=0.03; HRCOPDGene=1.079, 95% CI: 1.061, 1.096, P<0.001) textures with all-cause mortality independent of CT emphysema and Pi10.
INTERPRETATION
QCT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and overall disease burden in COPD.
期刊介绍:
At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.